{description: Clinicians should evaluate benefits and risks with patients within 1-4 weeks of starting opioid therapy for subacute or chronic pain or of dosage escalation. Clinicians should regularly reevaluate benefits and risks of continued opioid therapy with patients., package_name: fhir.cdc.opioid-cds-r4, name: PlanDefinition_Recommendation_07_Order_Sign, type: '{:coding [{:system \"http://terminology.hl7.org/CodeSystem/plan-definition-type\", :code \"eca-rule\", :display \"ECA Rule\"}]}', package_version: 2022.1.0, class: unknown, kind: null, url: 'http://fhir.org/guides/cdc/opioid-cds/PlanDefinition/opioidcds-07', version: 2022.1.0}